Health
Clinical trial completion rates decline during COVID-19 pandemic – Science Daily
Social distancing and lockdowns may have affected clinical researchers’ ability to finish trials, researchers report. Study completion rates dropped worldwide between…
Social distancing and lockdowns may have reduced the spread of COVID-19, but researchers from Penn State College of Medicine also report those actions may have affected clinical researchers’ ability to finish trials. Study completion rates dropped worldwide between 13% and 23%, depending on the type of research sponsor and geographic location, between April and October 2020.Researchers previously reported that more than 80% of clinical trials suspended between March 1 and April 26, 2020, noted the…
-
Business15 hours agoTop brokers name 3 ASX shares to buy next week 16 November 2025
-
Business18 hours ago3 US dividend stocks that can boost an ASX retirement portfolio
-
Business14 hours agoASX 200 mining shares rip as lithium makes a comeback
-
General22 hours agoDemocratic Republic of Congo and M23 rebel group sign new roadmap to peace in Qatar